Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection

NCT04359862 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Low recruitment ratio

Conditions

Acute Respiratory Distress Syndrome
COVID19 Infection

Interventions

DRUG: Sevoflurane
DRUG: Propofol

Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia